Sirnaomics (HKG:2257) and its wholly owned subsidiary, Sirnaomics (Hong Kong) Limited, filed a Writ of Summons in Hong Kong's High Court against former management members over the group's approximately US$20 million investment in a segregated portfolio of TradArt Flagship Investment.
The case, filed against Lu Yang, Xiaochang Dai and Yip Wing Kei, alleges breaches of duties and unauthorized handling of the investment, according to a Friday Hong Kong bourse filing.
Sirnaomics is seeking damages, compensation, interest and costs.
Shares of the biotechnology company fell nearly 1% in Monday's trade.